NYLIM
PFE icon

New York Life Investment Management’s Pfizer PFE Stock Holding History

New York Life Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.1M Buy
794,237
+3,917
+0.5% +$102K 0.13% 132
2026
Q1 		$22.2M Buy
790,320
+11,422
+1% +$304K 0.19% 103
2025
Q4 		$19.4M Buy
778,898
+7,435
+1% +$187K 0.17% 116
2025
Q3 		$19.7M Sell
771,463
-29,908
-4% -$738K 0.17% 114
2025
Q2 		$19.4M Buy
801,371
+16,995
+2% +$396K 0.18% 112
2025
Q1 		$19.9M Sell
784,376
-2,144
-0.3% -$56.1K 0.2% 104
2024
Q4 		$20.9M Buy
786,520
+9,007
+1% +$244K 0.2% 93
2024
Q3 		$22.5M Sell
777,513
-24,323
-3% -$710K 0.22% 95
2024
Q2 		$22.4M Buy
801,836
+5,603
+0.7% +$154K 0.23% 84
2024
Q1 		$22.1M Sell
796,233
-27,977
-3% -$776K 0.22% 86
2023
Q4 		$23.7M Sell
824,210
-59,492
-7% -$1.8M 0.24% 76
2023
Q3 		$29.3M Sell
883,702
-3,711
-0.4% -$131K 0.32% 60
2023
Q2 		$32.6M Buy
887,413
+9,642
+1% +$375K 0.34% 54
2023
Q1 		$35.8M Buy
877,771
+12,038
+1% +$520K 0.4% 44
2022
Q4 		$44.4M Sell
865,733
-1,317
-0.2% -$63.1K 0.51% 34
2022
Q3 		$37.9M Buy
867,050
+1,403
+0.2% +$68.2K 0.46% 38
2022
Q2 		$45.4M Buy
+865,647
New +$44.1M 0.53% 32

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

New York Life Investment Management's PFE Position: Q2 2026 in Review

New York Life Investment Management increased its Pfizer (PFE) stake by 0.5% in Q2 2026, buying an estimated $102K and bringing the position to 794,237 shares worth $19.1M. The position accounts for 0.13% of the portfolio, ranked #132.

New York Life Investment Management first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $45.4M in Q2 2022. 2,239 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • New York Life Investment Management held 794,237 shares of Pfizer worth $19.1M as of Q2 2026.
  • New York Life Investment Management bought 3,917 Pfizer shares in Q2 2026, an estimated $102K.
  • Pfizer made up 0.13% of New York Life Investment Management's portfolio in Q2 2026, its #132 holding.
  • New York Life Investment Management first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
  • New York Life Investment Management's Pfizer position peaked at $45.4M in Q2 2022.
  • 2,239 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.